Immunogenicity of Heterologous Versus Homologous Prime Boost Schedule With mRNA and Inactivated COVID-19 Vaccines
NCT05668065
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
199
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
BIOLOGICAL:
CoronaVac/CoronaVac
BIOLOGICAL:
CoronaVac/BNT162b2
Sponsor
Institut Pasteur de Tunis